Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.1300.288.664
Address
Level 5 126 Phillip Street Sydney, New South Wales (NSW) 2000
Description
Shekel Brainweigh Ltd. engages in the design and manufacture of weighing systems for retail, healthcare and industrial sectors. Its products include healthcare, retail innovations, and retail & OEM. The firm operates into two segments: Traditional and New Technologies. The company was founded on March 18, 2018 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.1
Trade Value (12mth)
AU$542.00
1 week
-13.79%
1 month
16.28%
YTD
-37.5%
1 year
-50%
All time high
0.40
EPS 3 yr Growth
-2.800%
EBITDA Margin
-8.40%
Operating Cashflow
-$4m
Free Cash Flow Return
-45.10%
ROIC
-98.60%
Interest Coverage
-1.60
Quick Ratio
0.50
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Industrials
Next Company Report Date
27-Feb-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
13 June 24 |
Appendix 3X and Appendix 3Z
×
Appendix 3X and Appendix 3Z |
22 May 24 |
Results of Meeting
×
Results of Meeting |
19 April 24 |
Notice of Annual General Meeting and Proxy Form
×
Notice of Annual General Meeting and Proxy Form |
17 April 24 |
Change of Chairman and CEO
×
Change of Chairman and CEO |
15 April 24 |
Response to ASX Query Letter
×
Response to ASX Query Letter |
02 April 24 |
Q1 2024 Shekel Brainweigh Business Update
×
Q1 2024 Shekel Brainweigh Business Update |
27 March 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 March 24 |
FY23 Annual Report and Consolidated Financial Statements
×
FY23 Annual Report and Consolidated Financial Statements |
27 March 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
26 March 24 |
Loan and Option Agreement Update
×
Loan and Option Agreement Update |
28 February 24 |
Appendix 4E and Preliminary Final Report
×
Appendix 4E and Preliminary Final Report |
28 February 24 |
FY23 Results Announcement
×
FY23 Results Announcement |
05 February 24 |
Shekel Launches Sentinel at NRF NY
×
Shekel Launches Sentinel at NRF NY |
22 January 24 |
Record FY2023 revenue of US$27.2million (unaudited)
×
Record FY2023 revenue of US$27.2million (unaudited) |
08 January 24 |
Application for quotation of securities - SBW
×
Application for quotation of securities - SBW |
08 January 24 |
Cleansing Notice
×
Cleansing Notice |
03 January 24 |
Notification regarding unquoted securities - SBW
×
Notification regarding unquoted securities - SBW |
14 December 23 |
Notification regarding unquoted securities - SBW
×
Notification regarding unquoted securities - SBW |
12 December 23 |
Proposed issue of securities - SBW
×
Proposed issue of securities - SBW |
01 December 23 |
SBW draws down Tranche 2 under loan and option agreement
×
SBW draws down Tranche 2 under loan and option agreement |
16 October 23 |
Q3 Revenue Growth and Israel Security Situation Update
×
Q3 Revenue Growth and Israel Security Situation Update |
22 September 23 |
Notification regarding unquoted securities - SBW
×
Notification regarding unquoted securities - SBW |
14 September 23 |
Investor Presentation
×
Investor Presentation |
30 August 23 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
03 August 23 |
SBW H1 2023 Update
×
SBW H1 2023 Update |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.